SCHEMBL4322602

SCHEMBL4322602

O=[N+]([O-])c1cc(Cl)ccc1C=Cc1n[nH]c2ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.47
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
MAPK1 P28482 2/20 0.47
LMNA P02545 1/20 0.47
AURKA O14965 2/20 0.43
AURKB Q96GD4 2/20 0.43
PIM1 P11309 2/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
POLB P06746 4/20 0.39
HPGD P15428 3/20 0.38
PDE7A Q13946 2/20 0.38
KDM4A O75164 1/20 0.38
KDM4B O94953 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PDE7B Q9NP56 1/20 0.38
PIM3 Q86V86 1/20 0.38
CHEK1 O14757 3/20 0.37
CDK4 P11802 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4322598 1.00 MAPT (0.47) MAPTMEN1KMT2AMAPK1LMNA
SCHEMBL4315404 0.85 NPC1 (0.50) MAPTMEN1KMT2ALMNAAURKA
SCHEMBL4315408 0.85 NPC1 (0.50) MAPTMEN1KMT2ALMNAAURKA
SCHEMBL4315416 0.83 AURKA (0.41) MAPTMEN1KMT2AMAPK1LMNA
SCHEMBL4320481 0.83 PTGS2 (0.52) MAPTAURKAAURKBFGFR1KDR
SCHEMBL4320483 0.83 PTGS2 (0.52) MAPTAURKAAURKBFGFR1KDR
SCHEMBL4312118 0.83 KDR (0.46) KMT2AMAPK1LMNAAURKAAURKB
SCHEMBL4312113 0.83 KDR (0.46) KMT2AMAPK1LMNAAURKAAURKB
SCHEMBL4315409 0.83 AURKA (0.41) MAPTMEN1KMT2AMAPK1LMNA
SCHEMBL4315197 0.80 NOS1 (0.44) MAPTMEN1KMT2AMAPK1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101111483-B IGF-1R inhibitors KYOWA HAKKO KIRIN CO.,LTD. (JP) 2011-12-14 CN disclosed
US-7605272-B2 IGF-1R inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2009-10-20 US disclosed
US-20090054508-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 US disclosed
CN-101111483-A IGF-1R inhibitors KYOWA HAKKO KOGYO KK (JP) 2008-01-23 CN disclosed
EP-1847532-A1 IGF-1R INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2007-10-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054508-A1 IGF-1R INHIBITOR IGF1R, IGFBP5, IGFBP1 MAPT 4175/4885MEN1 1830/4885KMT2A 1924/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.